Results 41 to 50 of about 1,862,769 (263)

Infection of non-cancer cells: A barrier or support for oncolytic virotherapy?

open access: yesMolecular Therapy: Oncolytics, 2022
Oncolytic viruses are designed to specifically target cancer cells, sparing normal cells. Although numerous studies demonstrate the ability of oncolytic viruses to infect a wide range of non-tumor cells, the significance of this phenomenon for cancer ...
Victor A. Naumenko   +4 more
doaj   +1 more source

Designing and Building Oncolytic Viruses [PDF]

open access: yesFuture Virology, 2017
Oncolytic viruses (OVs) are engineered and/or evolved to propagate selectively in cancerous tissues. They have a dual mechanism of action; direct killing of infected cancer cells cross-primes anticancer immunity to boost the killing of uninfected cancer cells.
Maroun, Justin   +5 more
openaire   +2 more sources

Combining of Oncolytic Virotherapy and Other Immunotherapeutic Approaches in Cancer: A Powerful Functionalization Tactic

open access: yesGlobal Challenges, 2023
Oncolytic viruses have found a good place in the treatment of cancer. Administering oncolytic viruses directly or by applying genetic changes can be effective in cancer treatment through the lysis of tumor cells and, in some cases, by inducing immune ...
Hai Zou, Xiao‐Zhou Mou, Biao Zhu
doaj   +1 more source

The gamble between oncolytic virus therapy and IFN

open access: yesFrontiers in Immunology, 2022
Various studies are being conducted on oncolytic virotherapy which one of the mechanisms is mediating interferon (IFN) production by it exerts antitumor effects.
Qingbo Li   +10 more
doaj   +1 more source

Strategies for Advanced Oncolytic Virotherapy: Current Technology Innovations and Clinical Approaches

open access: yesPharmaceutics, 2022
Oncolytic virotherapy is a type of nanomedicine with a dual antitumor mechanism. Viruses are engineered to selectively infect and lyse cancer cells directly, leading to the release of soluble antigens which induce systemic antitumor immunity ...
Qing Ji   +4 more
doaj   +1 more source

Table_1_Clinical Trials of Oncolytic Viruses in Breast Cancer.docx [PDF]

open access: yes, 2021
Breast cancer is the second most common kind of cancer worldwide and oncolytic viruses may offer a new treatment approach. There are three different types of oncolytic viruses used in clinical trials; (i) oncolytic viruses with natural anti-neoplastic ...
André Koch (8770430)   +3 more
core   +1 more source

Oncolytic Viruses in Combination Therapeutic Approaches with Epigenetic Modulators: Past, Present, and Future Perspectives

open access: yesCancers, 2021
Simple Summary Cancer rates have been accelerating significantly in recent years. Despite notable advances having been made in cancer therapy, and numerous studies being currently conducted in clinical trials, research is always looking for new treatment.
A. Chianese   +7 more
semanticscholar   +1 more source

Remodeling of Tumor Immune Microenvironment by Oncolytic Viruses

open access: yesFrontiers in Oncology, 2021
Oncolytic viruses (OVs) are potential antitumor agents with unique therapeutic mechanisms. They possess the ability of direct oncolysis and the induction of antitumor immunity.
Bin Zhang, Xilei Wang, P. Cheng
semanticscholar   +1 more source

Oncolytic viruses in malignant pleural mesothelioma [PDF]

open access: yes, 2022
Mesothelioma is an aggressive cancer of the serosal membranes with a median survival of 9 to 12 months. Oncolytic viruses are a next-generation therapy. The viruses directly lyse cancer cells and prime the immune system.
Ladhar, Pamelbir
core   +1 more source

Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles [PDF]

open access: yes, 2010
Targeted therapy of cancer using oncolytic viruses has generated much interest over the past few years in the light of the limited efficacy and side effects of standard cancer therapeutics for advanced disease.
Wang, YH   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy